Free cash flow vs Sales growth at constant exchange rates

In 2026, free cash flow worldwide was 2,670 million EUR; sales growth at constant exchange rates was 17.8%.

Change the pair

Compare different indicators

The series

Over time

Global, spaced by time in 2026 . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.

Free cash flow

Unit: million EUR · 2 observations

Line chart
Free cash flowFree cash flow. 2 observations from Q1 2026 to Q2 2026, ranging from 2,670 million EUR to 3,724 million EUR. Latest value 2,670 million EUR (Q2 2026). million EUR 0 1,000 2,000 3,000 4,000 8 Jan 15 Jan 22 Jan 5 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 3,724 2,670
Free cash flowFree cash flow. 2 observations from Q1 2026 to Q2 2026, ranging from 2,670 million EUR to 3,724 million EUR. Latest value 2,670 million EUR (Q2 2026). million EUR 0 1,000 2,000 3,000 4,000 8 Jan 15 Jan 22 Jan 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 3,724 2,670
Free cash flowFree cash flow. 2 observations from Q1 2026 to Q2 2026, ranging from 2,670 million EUR to 3,724 million EUR. Latest value 2,670 million EUR (Q2 2026). million EUR 0 1,000 2,000 3,000 4,000 8 Jan 22 Mar Feb 2026 Mar 2026 3,724 2,670
View the underlying data
Free cash flow
Period Type Value
Q1 2026 Actual 3,724 million EUR
Q2 2026 Actual 2,670 million EUR
Source: Sanofi · CC BY 4.0 · Full series

Sales growth at constant exchange rates

Unit: % · 2 observations

Line chart
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 15 Jan 22 Jan 5 Feb 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 15 Jan 22 Jan 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 22 Mar Feb 2026 Mar 2026 3% 18%
View the underlying data
Sales growth at constant exchange rates
Period Type Value
Q1 2026 Actual 3%
Q2 2026 Actual 17.8%
Source: Roche, Sanofi · CC BY 4.0 · Full series

Shared periods

Side by side

Only one period is published for both series. Comparing anything else would mean comparing different years.

Period Free cash flow Sales growth at constant exchange rates
2026 2,670 million EUR 17.8%

Provenance

Where these numbers come from

Free cash flow

Operating cash flow less capital expenditures generated by pharmaceutical and operational activities.

2 observations in Global · source organisations: Sanofi

Sales growth at constant exchange rates

Percentage change in sales calculated at constant exchange rates over the specified period.

2 observations in Global · source organisations: Roche, Sanofi

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related